US Stock MarketDetailed Quotes

VRTX Vertex Pharmaceuticals

Watchlist
  • 422.012
  • +3.022+0.72%
Trading May 10 14:18 ET
108.90BMarket Cap27.39P/E (TTM)

Vertex Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Vertex Pharmaceuticals Earnings Date

Currency: USD

Period

Q1 FY2024 Earnings

--

Revenue(YoY)

2.69B

+13.30%
EPS(YoY)

4.21

+56.51%
Analyst Rating

Buy

May 10, 2024

Vertex Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 23 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 2.692B--
--2024/Q2-- / 2.662B--
--2024/Q12.691B / 2.580B--
Feb 5, 20242023/Q42.518B / 2.515B--
Nov 6, 20232023/Q32.484B / 2.502B--
Aug 1, 20232023/Q22.493B / 2.421B--
May 1, 20232023/Q12.375B / 2.336B--
Feb 7, 20232022/Q42.303B / 2.303B--
Oct 27, 20222022/Q32.334B / 2.227B--
Aug 4, 20222022/Q22.196B / 2.132B--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 2.692B--
--2024/Q2-- / 2.662B--
--2024/Q12.691B / 2.580B--
Feb 5, 20242023/Q42.518B / 2.515B--
Nov 6, 20232023/Q32.484B / 2.502B--
Aug 1, 20232023/Q22.493B / 2.421B--
May 1, 20232023/Q12.375B / 2.336B--
Feb 7, 20232022/Q42.303B / 2.303B--
Oct 27, 20222022/Q32.334B / 2.227B--
Aug 4, 20222022/Q22.196B / 2.132B--

Unlock Free Earnings Estimates

Vertex Pharmaceuticals Earnings Reports

  • Vertex Pharmaceuticals | 10-Q: Quarterly report

    May 8 04:50

  • Vertex Pharmaceuticals | 10-K: Annual report

    Feb 16 05:20

  • Vertex Pharmaceuticals: Q3 2023 Earnings Report

    Nov 8, 2023 05:16

  • Vertex Pharmaceuticals | 10-Q: Q2 2023 Earnings Report

    Aug 3, 2023 04:05

    • Read more

    Analysis

    Analyst Rating

    Updated: May 10, 2024

    Buy

    • Buy

      76.00%

    • Hold

      16.00%

    • Sell

      8.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    %Chg
    Concept Gene Editing
    Gene Editing
    Intraday+0.99%